Zorayr ManukyanAdaptive Designs: A Ray of Hope for Early-Stage Clinical TrialsClinical trials are a cornerstone in medical research, playing an invaluable role in pushing the boundaries of medical science. However…Aug 26, 2023
Zorayr ManukyanTransforming Clinical Trials with Groundbreaking Design StrategiesThe landscape of clinical trials, a cornerstone of medical advancement, is constantly changing. As we strive to understand and treat…Jul 25, 2023
Zorayr ManukyanEfficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With…Michael F. Robinson,1 Nemanja Damjanov,2 Bojana Stamenkovic,3 Goran Radunovic,2 Alan Kivitz,4 Lori Cox,5 Zorayr Manukyan,5 Christopher…Jul 12, 2022Jul 12, 2022
Zorayr ManukyanStatistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive…AffiliationsMar 12, 2016Mar 12, 2016
Zorayr ManukyanCentral site monitoring: results from a test of accuracy in identifying trials and sites failing…AbstractApr 12, 2014Apr 12, 2014
Zorayr ManukyanAdaptive Designs: A Ray of Hope for Early-Stage Clinical TrialsClinical trials are a cornerstone in medical research, playing an invaluable role in pushing the boundaries of medical science. However…Aug 26, 2023
Zorayr ManukyanTransforming Clinical Trials with Groundbreaking Design StrategiesThe landscape of clinical trials, a cornerstone of medical advancement, is constantly changing. As we strive to understand and treat…Jul 25, 2023
Zorayr ManukyanEfficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With…Michael F. Robinson,1 Nemanja Damjanov,2 Bojana Stamenkovic,3 Goran Radunovic,2 Alan Kivitz,4 Lori Cox,5 Zorayr Manukyan,5 Christopher…Jul 12, 2022
Zorayr ManukyanStatistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive…AffiliationsMar 12, 2016
Zorayr ManukyanCentral site monitoring: results from a test of accuracy in identifying trials and sites failing…AbstractApr 12, 2014
